Search
CytomX Therapeutics Inc
CTMXAdd to Watchlist
3.220USD
+0.120+3.87%
Close 07-31 16:00（ET）Quotes delayed by 15 min
548.00MMarket Cap
LossP/E TTM
CytomX Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of CytomX Therapeutics Inc is 8.80, ranking 55 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.95, which is -509.52% below the recent high of 24.38 and -5868.70% above the recent low of -355.38.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.